From: Impact of corticosteroids and immunosuppressive therapies on symptomatic SARS-CoV-2 infection in a large cohort of patients with chronic inflammatory arthritis
OR
95% CI
p
 Disease duration ≥ 120 months
0.71
0.50 to 0.99
0.04
 Home lockdown
1.02
0.64 to 1.60
0.94
 PDN
1.23
1.04 to 1.44
0.02
 csDMARDs
0.89
0.55 to 1.43
0.62
 b/tsDMARDs
0.47
0.46 to 0.48
< 0.001
 AUC 0.62